COMMUNIQUÉS West-GlobeNewswire

-
Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi
02/06/2025 -
Sanofi Exercises License Extension Option to Nurix’s STAT6 Program
02/06/2025 -
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
02/06/2025 -
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
02/06/2025 -
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
02/06/2025 -
Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist
02/06/2025 -
Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance
02/06/2025 -
AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
02/06/2025 -
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2025 -
BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025
02/06/2025 -
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
02/06/2025 -
BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
02/06/2025 -
IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival
02/06/2025 -
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
02/06/2025 -
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
02/06/2025 -
Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology
02/06/2025 -
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer
02/06/2025 -
Bitterroot Bio Announces Dosing of First Patient in MATADOR Phase 2a Study of BRB-002, an Immunomodulating Therapy Targeting CD47 in Atherosclerotic Cardiovascular Disease
02/06/2025 -
Confluent Health Releases Groundbreaking Documentary to Tackle America’s Chronic Pain Crisis
02/06/2025
Pages